Removal from the plasma of the free and esterified forms of cholesterol and transfer of lipids to HDL in type 2 diabetes mellitus patients

<p>Abstract</p> <p>Background</p> <p>The aim was to investigate new markers for type 2 diabetes (T2DM) dyslipidemia related with LDL and HDL metabolism. Removal from plasma of free and esterified cholesterol transported in LDL and the transfer of lipids to HDL are impor...

Full description

Bibliographic Details
Main Authors: Oliveira Carolina P, Maranhão Raul C, Bertato Marina P, Wajchenberg Bernardo L, Lerario Antonio C
Format: Article
Language:English
Published: BMC 2012-06-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://www.lipidworld.com/content/11/1/65
Description
Summary:<p>Abstract</p> <p>Background</p> <p>The aim was to investigate new markers for type 2 diabetes (T2DM) dyslipidemia related with LDL and HDL metabolism. Removal from plasma of free and esterified cholesterol transported in LDL and the transfer of lipids to HDL are important aspects of the lipoprotein intravascular metabolism. The plasma kinetics (fractional clearance rate, FCR) and transfers of lipids to HDL were explored in T2DM patients and controls, using as tool a nanoemulsion that mimics LDL lipid structure (LDE).</p> <p>Results</p> <p><sup>14</sup>C- cholesteryl ester FCR of the nanoemulsion was greater in T2DM than in controls (0.07 ± 0.02 vs. 0.05 ± 0.01 h<sup>-1</sup>, p = 0.02) indicating that LDE was removed faster, but FCR <sup>3</sup> H- cholesterol was equal in both groups. Esterification rates of LDE free-cholesterol were equal. Cholesteryl ester and triglyceride transfer from LDE to HDL was greater in T2DM (4.2 ± 0.8 vs. 3.5 ± 0.7%, p = 0.03 and 6.8 ± 1.6% vs. 5.0 ± 1.1, p = 0.03, respectively). Phospholipid and free cholesterol transfers were not different.</p> <p>Conclusions</p> <p>The kinetics of free and esterified cholesterol tended to be independent in T2DM patients and the lipid transfers to HDL were also disturbed. These novel findings may be related with pathophysiological mechanisms of diabetic macrovascular disease.</p>
ISSN:1476-511X